Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
2023-02-28 21:00
Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference
2023-02-28 21:00
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
2023-02-28 08:53
WAT Med initiates collaborative research study with The Ohio State University to test the effectiveness of EmeTerm - neuromodulation technology to manage nausea and vomiting
2023-02-28 02:15
Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology
2023-02-28 01:00
Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023
2023-02-27 21:00
The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection
2023-02-27 17:18
Singleron Biotechnologies and Macrogen Europe announce a strategic alliance
2023-02-27 16:00
Distinguished Acupuncturist in China, Zhaohui Zhang Publishes Paper on Neuromodulation as the Corresponding Author
2023-02-27 09:51
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
2023-02-25 05:05
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
2023-02-24 22:00
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
2023-02-24 20:00
Dr. Lilly Xu Named President of Shanghai ChemPartner
2023-02-24 05:53
Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F
2023-02-24 05:30
Structo announces a new generation of dental 3D printers powered by MSLA 2.0 for superior Total Cost of Ownership
2023-02-24 00:00
Rayence unveils the first X-ray detector technology utilizing SPAD technology
2023-02-23 21:00
Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)
2023-02-23 21:00
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
2023-02-23 13:01
150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy
2023-02-22 22:00
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration
2023-02-22 22:00
1
113
114
115
116
117
801